載入...
Cost effectiveness of the type II Boston keratoprosthesis
PURPOSE: Despite demonstrated cost effectiveness, not all corneal disorders are amenable to type I Boston keratoprosthesis (KPro) implantation. This includes patients with autoimmune diseases, such as Stevens–Johnson syndrome/toxic epidermal necrolysis. Type II KPro is implanted through the eyelids...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3178310/ https://ncbi.nlm.nih.gov/pubmed/21183944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2010.197 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|